EMD-65314

Single-particle
2.96 Å
EMD-65314
3D View Gallery
Deposition: 09/07/2025
Map released: 08/07/2026
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-65314

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9vt4 summary report (pdf.gz) Map-9vt4 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

EBOV GP/BA2-VHH complex

EMD-65314

Single-particle
2.96 Å
EMD-65314
3D View Gallery
Deposition: 09/07/2025
Map released: 08/07/2026
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Zaire ebolavirus, Ebola virus - Gabon (1994-1997), Vicugna pacos
Sample: EBOV GP/BA2 complex
Fitted models: 9vt4

Deposition Authors: Wang M , Gao Y, Jin T
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus.
Wang M , Zhang X, Li W, Yao Y , Li E, Zhang B, Zhou J , Liu S, Gao Y, Zhu Z, Zhu L, Liu M, Hu J, Peng C, Li F, Chen M, Liu H, Yao C, Shang Y, Yan F, Gong P , Jin T , Chiu S
(2026) Nat Commun , 17
PUBMED: 41839884
DOI: doi:10.1038/s41467-026-70464-6
ISSN: 2041-1723